pharmaphorum6d
GSK’s Relvar Ellipta comes out on top in real world study
GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by New York State Teachers Retirement System
New York State Teachers Retirement System lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.4% ...
pharmaphorum2d
FDA rejection scuppers AZ’s hopes of a COPD triple clash with GSK
Trelegy – based on corticosteroid fluticasone furoate, LAMA umeclidinium and LABA vilanterol and approved in 2017 – is central to GSK’s efforts to replace its COPD blockbuster Seretide ...
Medscape3d
Are Proton-Pump Inhibitors Beneficial for Patients with Poorly Controlled Asthma?
Because acid reflux can cause bronchoconstriction, NIH asthma guidelines state the following: "For patients who have poorly controlled asthma ... investigation for GERD [gastroesophageal reflux ...
Medscape6d
The Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome
The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...